Overview

This trial is active, not recruiting.

Condition osteoarthritis of the hip
Sponsor Rothman Institute Orthopaedics
Collaborator Stryker Orthopaedics
Trial identifier NCT00951145, RIFJPAR 09-01

Summary

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only

Primary Outcomes

Measure
The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem
time frame:

Secondary Outcomes

Measure
Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis
time frame:

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: 1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem. 2. Patients with hip fracture undergoing THA will also be included. 3. Patients willing and able to comply with follow-up requirements and self-evaluations.

Additional Information

Official title Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
Principal investigator Parvizi Javad, MD
Trial information was received from ClinicalTrials.gov and was last updated in April 2013.
Information provided to ClinicalTrials.gov by Rothman Institute Orthopaedics.